XYMOGEN REPORTS RECORD ACTIVITIES FOR Q1-2012 INCLUDING REVENUES, EDUCATIONAL DEVELOPMENT, SPONSORSHIPS AND NEW MANUFACTURING HEADQUARTERS

Dr. John Brimhall joins XYMOGEN as Director of Educational Development XYMOGEN Assumes Alternative Medicine Review Corporate Sponsorship Move to new 136,000 sq.ft. Manufacturing Headquarters set for April 30thORLANDO, Fla. – Monday, April 16, 2012 – Orlando-based company XYMOGEN today reported financial results for its first quarter FY-2012.  Q1-2012 Financial Highlights · XYMOGEN posted Q1-2012 revenues / earnings of $11.3 million / $151K compared to $9.4 million /$696K for Q1-2011.  This represents a 21 percent period-over-period revenue growth and exceeded the company’s